Skye Bioscience, Inc. · NASDAQ:SKYE

Schwab Andrew J. sold 33,892 Skye Bioscience, Inc. shares (Form 4)

Traded Sep 16, 2026 · Filed Sep 18, 2026

On Sep 16, 2026, Schwab Andrew J. (Director, 10% owner) sold 33,892 Skye Bioscience, Inc. shares at US$1.91 for US$64,734, leaving 5,616 shares. Filed Sep 18, 2026 (Form 4).

Sold
33,892 shares
Price
US$1.91
Value
US$64,734
Holding after
5,616 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 16, 2026Common StockSale32,607US$1.91142,463Indirect
Sep 16, 2026Common StockSale1,285US$1.915,616Indirect

Source

View original at SEC

Related